Mirum Pharmaceuticals Inc (MIRM)
Healthcare
Biotechnology
106.00 $
-5.9%
vs. previous close
Closing price · As of: 31. Jul 2026
Mirum Pharmaceuticals Inc (MIRM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -229 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -17 | -18 | -17 | 15 | -3.8 | 4.0 | -5.1 | -2.0 | 12 | 40 | 6.1 | -229 | -171 | |
| 1.3 | 2.7 | 5.5 | 5.7 | 5.9 | 6.1 | 6.1 | 6.1 | 6.1 | 6.1 | 6.1 | 6.9 | 25 | |
| 8.4 | 8.4 | 9.7 | 11 | 12 | 12 | 13 | 16 | 18 | 18 | 19 | 36 | 92 | |
| 57 | 7.8 | – | – | – | – | – | – | – | – | – | – | – | |
| -3.5 | -5.6 | -11 | 24 | 1.6 | -1.2 | -1.7 | -11 | -6.6 | 12 | -14 | 102 | 94 | |
| 0.1 | 0.0 | 5.0 | 0.0 | 11 | 10 | 0.0 | 0.0 | 0.1 | 0.2 | 0.6 | 0.7 | 1.6 | |
| 51 | -183 | -2.0 | 0.0 | -73 | -18 | 0.6 | -16 | -6.6 | -2.2 | 1.0 | -12 | -19 | |
| – | – | – | 0.0 | – | – | – | – | – | – | – | – | – | |
| 2.1 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 305 | – | – | – | – | 0.0 | 0.0 | – | – | – | – | – | – | |
| 115 | 207 | 1.8 | 1.2 | 7.3 | 3.9 | 5.3 | 6.4 | 8.7 | 16 | 9.0 | 270 | 304 | |
| 148 | 5.8 | -17 | 17 | -69 | -10 | -0.5 | -11 | 16 | 54 | 16 | 28 | 114 | |
| -17 | -18 | -22 | 15 | -15 | -6.2 | -5.1 | -2.0 | 12 | 39 | 5.5 | -229 | -173 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.